Published in Psychopharmacology (Berl) on April 09, 2003
Imaging GABAergic/Glutamatergic Drugs in Bipolar Alcoholics Alcoholics | NCT03220776
Towards a glutamate hypothesis of depression: an emerging frontier of neuropsychopharmacology for mood disorders. Neuropharmacology (2011) 2.79
Magnetic resonance spectroscopy studies of glutamate-related abnormalities in mood disorders. Biol Psychiatry (2010) 2.08
Evidence for deficient modulation of amygdala response by prefrontal cortex in bipolar mania. Psychiatry Res (2007) 1.93
Abnormal glutamatergic neurotransmission and neuronal-glial interactions in acute mania. Biol Psychiatry (2008) 1.58
Dysregulation of the behavioral approach system (BAS) in bipolar spectrum disorders: review of theory and evidence. Clin Psychol Rev (2008) 1.58
Rapid enhancement of glutamatergic neurotransmission in bipolar depression following treatment with riluzole. Neuropsychopharmacology (2009) 1.36
Bipolar disorder and mechanisms of action of mood stabilizers. Brain Res Rev (2009) 1.31
Neurometabolites in schizophrenia and bipolar disorder - a systematic review and meta-analysis. Psychiatry Res (2012) 1.23
Executive function in pediatric bipolar disorder and attention-deficit hyperactivity disorder: in search of distinct phenotypic profiles. Neuropsychol Rev (2010) 1.04
Chronic carbamazepine administration reduces N-methyl-D-aspartate receptor-initiated signaling via arachidonic acid in rat brain. Biol Psychiatry (2007) 0.96
The many roads to mitochondrial dysfunction in neuroimmune and neuropsychiatric disorders. BMC Med (2015) 0.94
A longitudinal pilot proton MRS investigation of the manic and euthymic states of bipolar disorder. Transl Psychiatry (2012) 0.91
Bipolar disorder comorbid with alcoholism: a 1H magnetic resonance spectroscopy study. J Psychiatr Res (2009) 0.89
NMDA Receptor Activity in Neuropsychiatric Disorders. Front Psychiatry (2013) 0.89
Sodium- and magnesium-valproate in vivo modulate glutamatergic and GABAergic synapses in the medial prefrontal cortex. Psychopharmacology (Berl) (2006) 0.88
Glutamatergic effects of divalproex in adolescents with mania: a proton magnetic resonance spectroscopy study. J Am Acad Child Adolesc Psychiatry (2012) 0.88
Two-dimensional J-resolved proton MR spectroscopy and prior knowledge fitting (ProFit) in the frontal and parietal lobes of healthy volunteers: assessment of metabolite discrimination and general reproducibility. J Magn Reson Imaging (2012) 0.86
Brain glutamatergic characteristics of pediatric offspring of parents with bipolar disorder. Psychiatry Res (2010) 0.84
Management of bipolar depression with lamotrigine: an antiepileptic mood stabilizer. Front Pharmacol (2015) 0.81
Disturbance of the glutamatergic system in mood disorders. Exp Neurobiol (2014) 0.80
Cerebrospinal fluid glutamate concentration correlates with impulsive aggression in human subjects. J Psychiatr Res (2013) 0.79
Phase-adjusted echo time (PATE)-averaging 1 H MRS: application for improved glutamine quantification at 2.89 T. NMR Biomed (2012) 0.79
Vitamin D3 Supplemental Treatment for Mania in Youth with Bipolar Spectrum Disorders. J Child Adolesc Psychopharmacol (2015) 0.78
Lamotrigine blocks NMDA receptor-initiated arachidonic acid signalling in rat brain: implications for its efficacy in bipolar disorder. Int J Neuropsychopharmacol (2011) 0.78
Trait-related alterations of N-acetylaspartate in euthymic bipolar patients: A longitudinal proton magnetic resonance spectroscopy study. J Affect Disord (2016) 0.75
Molecular Mechanisms of Bipolar Disorder: Progress Made and Future Challenges. Front Cell Neurosci (2017) 0.75
Contribution of methotrexate in precipitation of manic episode in bipolar affective disorder explored: a case report. Ther Adv Psychopharmacol (2013) 0.75
Six-month outcome in bipolar spectrum alcoholics treated with acamprosate after detoxification: a retrospective study. Int J Environ Res Public Health (2014) 0.75
Unique prefrontal GABA and glutamate disturbances in co-occurring bipolar disorder and alcohol dependence. Transl Psychiatry (2017) 0.75
Estimation of metabolite concentrations from localized in vivo proton NMR spectra. Magn Reson Med (1993) 15.51
Subgenual prefrontal cortex abnormalities in mood disorders. Nature (1997) 9.36
Glutamate and GABA systems as targets for novel antidepressant and mood-stabilizing treatments. Mol Psychiatry (2002) 3.01
Reduced cortical gamma-aminobutyric acid levels in depressed patients determined by proton magnetic resonance spectroscopy. Arch Gen Psychiatry (1999) 2.78
Cytoarchitectonic definition of prefrontal areas in the normal human cortex: II. Variability in locations of areas 9 and 46 and relationship to the Talairach Coordinate System. Cereb Cortex (1995) 2.50
Reductions in neuronal and glial density characterize the dorsolateral prefrontal cortex in bipolar disorder. Biol Psychiatry (2001) 2.32
Reduced glutamate in the anterior cingulate cortex in depression: an in vivo proton magnetic resonance spectroscopy study. Biol Psychiatry (2000) 2.14
Absolute concentrations of metabolites in the adult human brain in vivo: quantification of localized proton MR spectra. Radiology (1993) 2.09
Chronic lithium treatment robustly protects neurons in the central nervous system against excitotoxicity by inhibiting N-methyl-D-aspartate receptor-mediated calcium influx. Proc Natl Acad Sci U S A (1998) 1.75
The mania rating scale: scale construction and inter-observer agreement. Neuropharmacology (1978) 1.66
Effective electroconvulsive therapy reverses glutamate/glutamine deficit in the left anterior cingulum of unipolar depressed patients. Psychiatry Res (2003) 1.39
Cerebral metabolic rates for glucose in mood disorders. Studies with positron emission tomography and fluorodeoxyglucose F 18. Arch Gen Psychiatry (1985) 1.39
A neuropsychological investigation of prefrontal cortex involvement in acute mania. Am J Psychiatry (2001) 1.31
Functional imaging studies: linking mind and basic neuroscience. Am J Psychiatry (2001) 1.24
Molecular abnormalities in the major psychiatric illnesses: Classification and Regression Tree (CRT) analysis of post-mortem prefrontal markers. Mol Psychiatry (2002) 1.20
Metabolic changes within the left dorsolateral prefrontal cortex occurring with electroconvulsive therapy in patients with treatment resistant unipolar depression. Psychol Med (2003) 1.14
Differentiation of metabolic concentrations between gray matter and white matter of human brain by in vivo 1H magnetic resonance spectroscopy. Magn Reson Med (1998) 1.13
Frontosubcortical neuroanatomy and the continuous performance test in mania. Am J Psychiatry (1999) 1.05
Proton MR spectroscopy in children with bipolar affective disorder: preliminary observations. AJNR Am J Neuroradiol (2000) 1.02
Hippocampal and anterior cingulate activation deficits in patients with geriatric depression. Am J Psychiatry (2001) 1.00
Effect of population-based screening on breast cancer mortality. Lancet (2011) 5.06
Prospective multicenter cohort study to refine management recommendations for women at elevated familial risk of breast cancer: the EVA trial. J Clin Oncol (2010) 3.46
The incidence of interval cancers in the German mammography screening program: results from the population-based cancer registry in North Rhine-Westphalia. Dtsch Arztebl Int (2012) 2.99
Screening for early lung cancer with low-dose spiral CT: prevalence in 817 asymptomatic smokers. Radiology (2002) 2.92
Limbic scars: long-term consequences of childhood maltreatment revealed by functional and structural magnetic resonance imaging. Biol Psychiatry (2011) 2.60
Volumetric measurements of pulmonary nodules at multi-row detector CT: in vivo reproducibility. Eur Radiol (2003) 2.59
Infarction of tumor vessels by NGR-peptide-directed targeting of tissue factor: experimental results and first-in-man experience. Blood (2009) 2.54
Human fear conditioning and extinction in neuroimaging: a systematic review. PLoS One (2009) 2.37
Imaging studies for the early detection of breast cancer. Dtsch Arztebl Int (2008) 2.19
Optimal systolic and diastolic reconstruction windows for coronary CT angiography using dual-source CT. AJR Am J Roentgenol (2007) 2.11
Atrial fibrillation in stroke-free patients is associated with memory impairment and hippocampal atrophy. Eur Heart J (2008) 2.09
Screening for early lung cancer with low-dose spiral computed tomography: results of annual follow-up examinations in asymptomatic smokers. Eur Radiol (2004) 2.01
Associations between cognitive performance and cortisol reaction to the DEX/CRH test in patients recovered from depression. Psychoneuroendocrinology (2012) 1.99
S100B in brain damage and neurodegeneration. Microsc Res Tech (2003) 1.85
Cell tagging with clinically approved iron oxides: feasibility and effect of lipofection, particle size, and surface coating on labeling efficiency. Radiology (2005) 1.79
Interoceptive sensitivity in anxiety and anxiety disorders: an overview and integration of neurobiological findings. Clin Psychol Rev (2010) 1.78
Neural substrates of treatment response to cognitive-behavioral therapy in panic disorder with agoraphobia. Am J Psychiatry (2013) 1.71
Effect of cognitive-behavioral therapy on neural correlates of fear conditioning in panic disorder. Biol Psychiatry (2012) 1.70
Acute shift in glutamate concentrations following experimentally induced panic with cholecystokinin tetrapeptide--a 3T-MRS study in healthy subjects. Neuropsychopharmacology (2013) 1.67
Automatic mood-congruent amygdala responses to masked facial expressions in major depression. Biol Psychiatry (2010) 1.66
Diastolic isthmus length and 'vertical' isthmus angulation identify patients with difficult catheter ablation of typical atrial flutter: a pre-procedural MRI study. Europace (2008) 1.54
Neural activation underlying acute grief in women after the loss of an unborn child. Am J Psychiatry (2009) 1.52
Diagnosing delirium in older hospitalized adults with dementia: adapting the confusion assessment method to international classification of diseases, tenth revision, diagnostic criteria. J Am Geriatr Soc (2012) 1.48
Detection of pulmonary nodules at multirow-detector CT: effectiveness of double reading to improve sensitivity at standard-dose and low-dose chest CT. Eur Radiol (2004) 1.46
5-HTTLPR biases amygdala activity in response to masked facial expressions in major depression. Neuropsychopharmacology (2007) 1.44
Effective electroconvulsive therapy reverses glutamate/glutamine deficit in the left anterior cingulum of unipolar depressed patients. Psychiatry Res (2003) 1.39
Noninvasive grading of untreated gliomas: a comparative study of MR imaging and 3-(iodine 123)-L-alpha-methyltyrosine SPECT. Radiology (2002) 1.39
Clinical risk factors for weight gain during psychopharmacologic treatment of depression: results from 2 large German observational studies. J Clin Psychiatry (2015) 1.39
Low-voltage digital selenium radiography: detection of simulated interstitial lung disease, nodules, and catheters--a phantom study. Radiology (2004) 1.38
Multi-detector row CT of left ventricular function with dedicated analysis software versus MR imaging: initial experience. Radiology (2003) 1.32
Validation of a blood-based laboratory test to aid in the confirmation of a diagnosis of schizophrenia. Biomark Insights (2010) 1.30
Optical imaging of spontaneous breast tumors using protease sensing 'smart' optical probes. Invest Radiol (2005) 1.22
Cognitive impairment and in vivo metabolites in first-episode neuroleptic-naive and chronic medicated schizophrenic patients: a proton magnetic resonance spectroscopy study. J Psychiatr Res (2006) 1.22
Amygdala reactivity to masked negative faces is associated with automatic judgmental bias in major depression: a 3 T fMRI study. J Psychiatry Neurosci (2007) 1.22
Vascular endothelial growth factor protects cultured rat hippocampal neurons against hypoxic injury via an antiexcitotoxic, caspase-independent mechanism. J Cereb Blood Flow Metab (2002) 1.20
Magnetic resonance 4D flow analysis of cerebrospinal fluid dynamics in Chiari I malformation with and without syringomyelia. Eur Radiol (2012) 1.19
Reduced amygdala-prefrontal coupling in major depression: association with MAOA genotype and illness severity. Int J Neuropsychopharmacol (2008) 1.18
Metabolic changes after repetitive transcranial magnetic stimulation (rTMS) of the left prefrontal cortex: a sham-controlled proton magnetic resonance spectroscopy (1H MRS) study of healthy brain. Eur J Neurosci (2003) 1.17
Amygdala reactivity predicts automatic negative evaluations for facial emotions. Psychiatry Res (2006) 1.16
Decreased gray matter volumes in the cingulo-frontal cortex and the amygdala in patients with fibromyalgia. Psychosom Med (2009) 1.16
Association of the functional -1019C/G 5-HT1A polymorphism with prefrontal cortex and amygdala activation measured with 3 T fMRI in panic disorder. Int J Neuropsychopharmacol (2005) 1.15
Impact of working memory load on FMRI resting state pattern in subsequent resting phases. PLoS One (2009) 1.14
Association of the COMT val158met variant with antidepressant treatment response in major depression. Neuropsychopharmacology (2007) 1.13
Childhood maltreatment is associated with an automatic negative emotion processing bias in the amygdala. Hum Brain Mapp (2012) 1.12
High-resolution magnetic resonance imaging of the temporomandibular joint: image quality at 1.5 and 3.0 Tesla in volunteers. Invest Radiol (2007) 1.11
Altered brain activity during pain processing in fibromyalgia. Neuroimage (2008) 1.10
Detection of asymptomatic cerebral microbleeds: a comparative study at 1.5 and 3.0 T. Acad Radiol (2008) 1.10
64- Versus 16-slice CT angiography for coronary artery stent assessment: in vitro experience. Invest Radiol (2006) 1.10
Automatic detection of pulmonary nodules at spiral CT: clinical application of a computer-aided diagnosis system. Eur Radiol (2001) 1.10
Mammography Screening: Evidence, History and Current Practice in Germany and Other European Countries. Breast Care (Basel) (2011) 1.10
64-slice multidetector coronary CT angiography: in vitro evaluation of 68 different stents. Eur Radiol (2005) 1.10
Selective coronary artery plaque visualization and differentiation by contrast-enhanced inversion prepared MRI. Eur Heart J (2006) 1.09
Different activation patterns of proinflammatory cytokines in melancholic and non-melancholic major depression are associated with HPA axis activity. J Affect Disord (2005) 1.09
FLAIR imaging for multiple sclerosis: a comparative MR study at 1.5 and 3.0 Tesla. Eur Radiol (2005) 1.08
In vivo imaging of integrin alpha v beta 3 expression using fluorescence-mediated tomography. Eur J Nucl Med Mol Imaging (2006) 1.08
Increased amygdala activation during automatic processing of facial emotion in schizophrenia. Psychiatry Res (2010) 1.08
Prospective study of access site complications of automated contrast injection with peripheral venous access in MDCT. AJR Am J Roentgenol (2010) 1.07
Cross-disorder analysis of bipolar risk genes: further evidence of DGKH as a risk gene for bipolar disorder, but also unipolar depression and adult ADHD. Neuropsychopharmacology (2011) 1.07
Neurotrophic effects of electroconvulsive therapy: a proton magnetic resonance study of the left amygdalar region in patients with treatment-resistant depression. Neuropsychopharmacology (2002) 1.06
Cognitive dysfunction in mice deficient for TNF- and its receptors. Am J Med Genet B Neuropsychiatr Genet (2008) 1.05
Using ECG-gated multidetector CT to evaluate global left ventricular myocardial function in patients with coronary artery disease. AJR Am J Roentgenol (2002) 1.05
Evidence for glutamatergic neuronal dysfunction in the prefrontal cortex in chronic but not in first-episode patients with schizophrenia: a proton magnetic resonance spectroscopy study. Schizophr Res (2005) 1.04